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Introduction
•
•

•
•
•
•

Abnormal placentation is one of the important causes of obstetric hemorrhage.
The term “morbidly adherent placenta” describes a spectrum of disorders
including placenta accreta, increta and percreta with increasing degrees of
invasion of the uterus by placenta respectively with/without invasion into
adjacent structures.(1)
The rapidity of blood loss in these cases can become rapidly overwhelming
giving no time for an organised approach.
There is necessity for multi disciplinary planning for the safe peri-partum
management of the mother and baby.
Here we describe the case of a multigravid woman with placenta previa
percreta who bled massively leading to intraoperative cardiac arrest despite
adequate preparation in terms of personnel, planning and available resources.
We would like to further discuss the questions and dilemma that arose regarding
anesthetic plan and perioperative management of this patient with emphasis on
the lack of dedicated obstetric resuscitation guidelines in the face of acute
massive hemorrhage, which is not very uncommon in this population even in a
completely elective setting as above.

Learning Objectives
1.

Highlight the need for recommendations regarding anesthetic technique in
patients with abnormal placentation

2.

Contemplate the appropriateness of an epidural in patients prone to
coagulopathy from hemorrhage

3.

Emphasize that guidelines are needed to help direct transfusion during
obstetrical hemorrhage and to underscore that point of care testing such as
thromboelastogram (TEG) based blood component transfusion requires
validation in obstetric hemorrhage

Patient received combined spinal and epidural (not activated) for the ureteric stenting
with an aim to use the epidural for post-operative analgesia followed by general
anesthesia and establishment of invasive lines and monitoring prior to start of CH.
Soon after baby delivery, patient became hypotensive from severe hemorrhage.
Massive transfusion protocol was instituted. After completion of hysterectomy, patient
continued to bleed from multiple intraabdominal sites. While surgical hemostasis
remained a challenge, patient developed PEA arrest. CPR was started with return of
spontaneous circulation(ROSC) after chest compression for 2 minutes and 1mg of
epinephrine. Following this, abdomen was packed with a decision to close secondarily
after interventional radiology(IR) assisted intervention if necessary and hemodynamic
stabilization. Intraoperatively, patient received a total of 29pRBCs, 22FFP, 4platelet &
3Cryo units with 21 L of crystalloids, 3.25 L of 5% albumin and 1.8L of cell saver with
an estimated blood loss of 25L. Tranexamic acid and prothrombin complex concentrate
was given. Thromboelastogram(TEG) and lab based coagulation profile was used
intraoperatively to guide blood component transfusion. Serial blood gas analyses
guided volume and electrolyte correction. In the ICU patient improved with no
neurological insult or DIC. On postop day 1 IR found no active extravasations and
surgical abdominal closure was performed. Epidural catheter was used for
postoperative pain control and was removed on day 4. Patient was discharged on postop day 10.

Obstetric hemorrhage from abnormal placentation can be massive. MRI of the
abdomen may show invasion but imaging has no predictive value for hemorrhage
anticipation(2).
Preop IR guided procedures have been described and may decrease blood loss during
CH. However, reported complications including catheter migration and arterial
aneurysms leading to limb ischemia limit their use. Currently there is not enough
evidence to make this a routine practice. (3).
There is a recent shift towards conservative management with an aim to preserve
fertility and decreasing morbidity. In 2016, Konishi Y et al described conservatively
managing a patient with placenta praevia where after baby delivery and clamping of
placenta, uterine artery embolization and uterine closure was performed in a hybrid
OR suite (4). However an Australian retrospective study reported over 40 % of
women managed conservatively required emergent or elective hysterectomy and 42%
experienced major morbidity (5).
Trauma transfusion guidelines i.e., 1:1:1 ratio is not as validated for obstetric
hemorrhage(6). At present there are no transfusion guidelines for obstetric
hemorrhage management. Blood and blood product transfusion was managed
intraoperatively with the use of thromboelastogram (TEG) and lab based coagulation
profile. Volume resuscitation and electrolyte correction was monitored with serial
ABGs.
With no way to reliably predict which of these patients will bleed massively, it is
reasonable to approach these patients with invasive lines and monitoring and a rapid
infusor ready to go from the start with blood available. There may be a subset of
patients with percreta that would benefit from the conservative approach with all its
risks. Being able to predict severity of bleed may help risk stratify and guide in
planning peripartum management of these patients.
Team work and strong communication cannot be over emphasized in any crisis
management. Point of care testing and additional personnel support are indispensable
and may add to cost.
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Case Report
A 34 year old G6P5 diagnosed with placenta previa percreta (fig 1) in her 2nd
trimester was reviewed by a multidisciplinary team. Baby delivery was planned at 34
weeks gestation by cesarean hysterectomy(CH) immediately preceded by bilateral
ureteral stents for anticipated surgical complexity.

Discussion

Fig 1: USG image of the patient showing placenta covering the cervical os with fetal head in
vertex presentation.
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